Modified Hydrocyanine Dyes for the Detection of Reactive Oxygen Species
US-2018202936-A1 · Jul 19, 2018 · US
Compositions and methods for the treatment of inflammation
US10774059B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10774059-B2 |
| Application number | US-201916446604-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 19, 2019 |
| Priority date | Dec 19, 2016 |
| Publication date | Sep 15, 2020 |
| Grant date | Sep 15, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, intravenous, spray, parenteral, lozenge, solution, syrup, sachet, transdermal administration, or injection. Such compositions may be used to treatment of inflammation or its associated complications.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound selected from the group consisting of 2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier. 3. The pharmaceutical composition of claim 2 , wherein said pharmaceutical composition is formulated to for oral administration, delayed release or sustained release, transmucosal administration, syrup, topical administration, parenteral administration, injection, subdermal administration, oral solution, rectal administration, buccal administration or transdermal administration. 4. The pharmaceutical composition of claim 3 , wherein said pharmaceutical composition is formulated for the treatment of inflammation, inflammatory pain and post-surgery inflammation.
Assignees
Inventors
Classifications
polycyclic · CPC title
Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
- C07D317/12Primary
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms · CPC title
- C07D317/26Primary
Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10774059B2 cover?
- The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, intravenous, spray, parenteral, lozenge, solution, syrup, sachet, transdermal a…
- Who is the assignee on this patent?
- Cellix Bio Private Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D317/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).